All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • RinvaterceptKER-065Phase 21 trial

    Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy

  • RL-007InidascaminePhase 21 trial

    Recognify Life Sciences · Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia

  • RLY-2608Phase 21 trial

    Relay Therapeutics, Inc. · PIK3CA-Related Overgrowth Spectrum (PROS), Lymphatic Malformations, Vascular Malformations

  • RLY-8161Phase 21 trial

    Relay Therapeutics, Inc. · Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors, NRAS Mutation

  • RMC-035Phase 21 trial

    Guard Therapeutics AB · Kidney Injury Following Open-Chest Cardiac Surgery

  • RN0361Phase 21 trial

    Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome

  • RN3161Phase 21 trial

    Ikaria Bioscience Pty Ltd · Obesity &Amp; Overweight

  • RNDP-001Phase 21 trial

    Kenai Therapeutics · Idiopathic Parkinson´s Disease, Parkinson's Disease

  • RNK05047Phase 21 trial

    Ranok Therapeutics (Hangzhou) Co., Ltd. · Advanced Solid Tumor, DLBCL

  • RNK08954-01Phase 21 trial

    Ranok Therapeutics (Hangzhou) Co., Ltd. · KRAS G12D Mutation

  • RO0091978Phase 21 trial

    Roche (Genentech) · Metastatic Breast Cancer

  • RO6874281Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • RO7268489Phase 21 trial

    Roche (Genentech) · Progressive Multiple Sclerosis

  • RO7269162Phase 21 trial

    Roche (Genentech) · Alzheimer's Disease

  • RO7275887Phase 21 trial

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants

  • RO7446603Phase 21 trial

    Roche (Genentech) · Diabetic Macular Edema

  • RO7830698Phase 21 trial

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants

  • RO7837195Phase 21 trial

    Roche (Genentech) · Ulcerative Colitis

  • RO7965032Phase 21 trial

    Roche (Genentech) · Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • ROC-101Phase 21 trial

    AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease

  • RP-001Phase 21 trial

    Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer

  • RP902Phase 21 trial

    Risen (Suzhou) Pharma Tech Co., Ltd. · Mild Cognitive Impairment (MCI)

  • RR001Phase 21 trial

    EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma

  • RRG001Phase 21 trial

    Shanghai Refreshgene Technology Co., Ltd. · Neovascular Age-related Macular Degeneration

  • RRx-001Phase 21 trial

    EpicentRx, Inc. · Oral Mucositis

  • RS-113Phase 21 trial

    R-Pharm International, LLC · Metastatic Castration-resistant Prostate Cancer

  • RSLV-132Phase 21 trial

    Resolve Therapeutics · Primary Sjögren Syndrome

  • RSO-021ThiostreptonPhase 21 trial

    RS Oncology LLC · Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma

  • RSP-1502Phase 21 trial

    Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

  • RSS0343Phase 21 trial

    Reistone Biopharma Company Limited · Chronic Obstructive Pulmonary Disease

  • RT023Phase 21 trial

    Shanghai Ruotuo Biosciences Co., Ltd. · Advanced Malignant Solid Tumours

  • RT036Phase 21 trial

    Shanghai Ruotuo Biosciences Co., Ltd. · Advanced Malignant Solid Tumours

  • RTN-001SLx-2101Phase 21 trial

    Retension Pharmaceuticals. Inc. · Uncontrolled Hypertension

  • RTP-026Phase 21 trial

    ResoTher Pharma · ST Elevation Myocardial Infarction

  • RuzasvirAT-038Phase 21 trial

    Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C

  • RV001VPhase 21 trial

    RhoVac APS · Prostate Cancer Recurrent

  • RVP-001Mn-PyC3A, mangaveratePhase 21 trial

    Reveal Pharmaceuticals Inc. · Central Nervous System (CNS) Lesions, Brain Metastases, Brain Neoplasms

  • RXC007Phase 21 trial

    Redx Pharma Ltd · IPF, Fibrosis

  • RXRG001Phase 21 trial

    RiboX Therapeutics Ltd. · Radiation-Induced Xerostomia and Hyposalivation

  • RYZ711Phase 21 trial

    RayzeBio, Inc. · Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • RYZ801Phase 21 trial

    RayzeBio, Inc. · Hepatocellular Carcinoma (HCC)

  • S095018Phase 21 trial

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)

  • S095024Phase 21 trial

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)

  • S095035Phase 21 trial

    Servier Bio-Innovation LLC · MTAP-deleted Solid Tumors

  • S241656Phase 21 trial

    Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia

  • S243249Phase 21 trial

    Servier · Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Myeloid Leukemia

  • S247240Phase 21 trial

    Institut de Recherches Internationales Servier (I.R.I.S.) · Fragile X Syndrome (FXS)

  • SA53-OSPhase 21 trial

    Lamassu Bio Inc · Solid Tumor

  • SAB-142Phase 21 trial

    SAb Biotherapeutics, Inc. · Type 1 Diabetes

  • sabatolimabMBG453Phase 21 trial

    Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NewerPage 67 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.